Philips’ Miclot Moves to CCS, Spence Takes Over ‘Big Shoes’

MURRYSVILLE, Pa. — During Medtrade last month, Philips
Home Healthcare Solutions CEO John L. Miclot announced he had
resigned from Philips Respironics to take the top spot at CCS
Medical.

Based in Clearwater, Fla., CCS is one of the nation’s largest
providers of respiratory medications and diabetes testing supplies
to Medicare beneficiaries, offering mail-order delivery of HME
including blood glucose meters, catheters, insulin pumps,
nebulizers and ostomy, urological and wound care supplies.

Formed by the merger of Chronic Care Solutions and MP TotalCare,
CCS is majority-owned by private equity investor Warburg Pincus.
Ranked No. 56 on Inc.‘s 2007 list of Top 100
companies by dollars of growth and No. 64 in revenues, the company had 2006 sales
of $432 million and currently operates offices in seven states with
1,600 employees.

After joining Respironics in 1998 as group vice president, sleep
disorders, Miclot was tapped to lead the company in late 2003. He
was named CEO of Philips Home Healthcare Solutions following
Respironics’ acquisition by Philips in a $5.1 billion deal earlier
this year.

Currently serving as president of sleep and home respiratory for
Philips Respironics, Donald J. Spence will succeed Miclot. At a
press event during the Atlanta trade show, Spence noted he had big
shoes to fill and joked that, with CCS as a potential customer, “I
don’t look forward to the negotiating sessions.”